Trials / Completed
CompletedNCT05550844
Emphysema and FLNA Mutation (E-FLNA)
Frequency and Characteristics of Emphysema in Patients With a FLNA Gene Mutation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Some sparse scientific data support the hypothesis that otherwise unexplained emphysema may be associated with FLNA mutation. This prospective, monocentric, cross-sectional study aimed to describe the frequency of emphysema in patients carrying an FLNA mutation. Patients with FLNA mutations who accept the study will benefit from a chest physician's clinical examination, respiratory function tests and a chest scan. The primary endpoint is to describe emphysema's frequency in patients carrying FLNA mutation. The other objectives are to describe emphysema's features in these patients and to describe their lung function abnormalities. The final goal is to confirm the association between unexplained emphysema and FLNA mutation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Chest HRCT | A chest HRCT to identify emphysema |
| GENETIC | blood analysis | If emphysema is identified, a blood analysis will be performed to exclude known causes of emphysema (Alpha-1 antitrypsin deficiency, PTPN6 mutation) |
| OTHER | Lung function tests | Lung function tests will be performed in accordance with ATS/ERS technical standard |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2023-10-23
- Completion
- 2023-10-23
- First posted
- 2022-09-22
- Last updated
- 2026-02-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05550844. Inclusion in this directory is not an endorsement.